Evolus (EOLS) Stock Chart & Stock Price History $12.60 -0.44 (-3.37%) (As of 11/22/2024 ET) Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Evolus Stock Price Performance 5 Day Performance+5.09%1 Month Performance-19.39%3 Month Performance-20.55%6 Month Performance+1.20%Year-To-Date Performance+19.66%1 Year Performance+34.04% Receive EOLS Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Evolus and its competitors with MarketBeat's FREE daily newsletter. Email Address I hate to say I told you so (Ad)Last month, I openly declared that a Trump Presidency was going to kick off Tesla’s New Bullish Cycle Folks who listened and bought in when I said to are currently crushing it. As a matter of fact, all the trades we’ve opened ever since I made that public declaration have ALL been winners. And it’s simply because this Tesla indicator just flipped green on the stock…Follow this link right away. EOLS Stock Chart for Saturday, November, 23, 2024 EOLS Chart by TradingView Evolus Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization11/22/2024$13.09$12.60-3.71%$13.25$12.46783,751 shs$797.85 million11/21/2024$12.63$13.09+3.61%$13.20$12.53759,018 shs$828.59 million11/20/2024$12.39$12.63+1.94%$12.65$12.17429,714 shs$799.73 million11/19/2024$11.99$12.39+3.34%$12.65$11.88617,022 shs$784.54 million11/18/2024$12.11$11.99-0.99%$12.65$11.95676,297 shs$759.22 million11/15/2024$11.88$12.11+1.94%$12.13$11.371.16 million shs$766.81 million Get the Latest News and Ratings for EOLS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Evolus and its competitors with MarketBeat's FREE daily newsletter. 11/14/2024$12.25$11.88-3.02%$12.46$11.86578,864 shs$752.25 million11/13/2024$12.44$12.25-1.53%$12.70$12.20695,855 shs$775.68 million11/12/2024$13.12$12.44-5.18%$13.05$12.41938,701 shs$787.70 million11/11/2024$13.68$13.12-4.09%$13.88$12.97730,902 shs$830.76 million11/08/2024$14.29$13.68-4.27%$14.35$13.351.28 million shs$863.07 million11/07/2024$16.81$14.29-14.99%$15.59$14.262.05 million shs$901.56 million11/06/2024$16.49$16.81+1.94%$17.44$16.471.04 million shs$1.06 billion11/05/2024$16.42$16.49+0.43%$16.69$16.27288,203 shs$1.04 billion11/04/2024$16.75$16.42-1.97%$16.65$16.12327,932 shs$1.04 billion11/01/2024$16.32$16.75+2.63%$16.77$16.35374,201 shs$1.06 billion10/31/2024$16.75$16.32-2.57%$16.73$16.03299,944 shs$1.02 billion10/30/2024$16.69$16.75+0.36%$16.98$15.95469,300 shs$1.05 billion10/29/2024$16.27$16.69+2.58%$16.72$16.06273,057 shs$1.04 billion10/28/2024$16.46$16.27-1.15%$16.78$16.23358,116 shs$1.02 billion10/25/2024$15.79$16.46+4.24%$16.58$15.72447,114 shs$1.03 billion10/24/2024$15.63$15.79+1.02%$16.07$15.56269,371 shs$988.45 million10/23/2024$16.04$15.63-2.56%$16.08$15.51277,013 shs$978.44 million10/22/2024$16.24$16.04-1.23%$16.33$15.89319,631 shs$1.00 billion Related Companies MoonLake Immunotherapeutics Stock Chart PTC Therapeutics Stock Chart Agios Pharmaceuticals Stock Chart HUTCHMED Stock Chart Merus Stock Chart Xenon Pharmaceuticals Stock Chart Edgewise Therapeutics Stock Chart Verona Pharma Stock Chart Dyne Therapeutics Stock Chart Bausch Health Companies Stock Chart Receive EOLS Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Evolus and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:EOLS) was last updated on 11/23/2024 by MarketBeat.com Staff From Our PartnersMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredBut another coin could soar even higher …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin co...Weiss Ratings | SponsoredElon knows the truth, which is why they want him silencedElon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to h...Porter & Company | Sponsored24/7 Automated Profits in CryptoThe 4th quarter of 2024 is shaping up to be one of the most explosive periods for crypto in recent memory. But...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Evolus, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Evolus With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
